SE435180B - Hydroxiderivat av 2-isopropylamino-pyrimidin och sett for framstellning derav - Google Patents

Hydroxiderivat av 2-isopropylamino-pyrimidin och sett for framstellning derav

Info

Publication number
SE435180B
SE435180B SE8001812A SE8001812A SE435180B SE 435180 B SE435180 B SE 435180B SE 8001812 A SE8001812 A SE 8001812A SE 8001812 A SE8001812 A SE 8001812A SE 435180 B SE435180 B SE 435180B
Authority
SE
Sweden
Prior art keywords
pyrimidine
hydrogen atom
isopropylamino
derivatives
preparing
Prior art date
Application number
SE8001812A
Other languages
English (en)
Swedish (sv)
Other versions
SE8001812L (sv
Inventor
A Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE435180(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of SE8001812L publication Critical patent/SE8001812L/xx
Publication of SE435180B publication Critical patent/SE435180B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8001812A 1979-03-10 1980-03-07 Hydroxiderivat av 2-isopropylamino-pyrimidin och sett for framstellning derav SE435180B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (2)

Publication Number Publication Date
SE8001812L SE8001812L (sv) 1980-09-11
SE435180B true SE435180B (sv) 1984-09-10

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001812A SE435180B (sv) 1979-03-10 1980-03-07 Hydroxiderivat av 2-isopropylamino-pyrimidin och sett for framstellning derav

Country Status (24)

Country Link
JP (1) JPS55122768A (xx)
AR (1) AR222691A1 (xx)
AU (1) AU533547B2 (xx)
BE (1) BE881752A (xx)
CA (1) CA1132561A (xx)
CH (1) CH644368A5 (xx)
DE (3) DE3050999C2 (xx)
EG (1) EG14282A (xx)
FI (1) FI66357C (xx)
FR (2) FR2451370A1 (xx)
GB (1) GB2045756B (xx)
HK (1) HK55383A (xx)
IE (1) IE49547B1 (xx)
IN (1) IN153791B (xx)
LU (1) LU82185A1 (xx)
MX (1) MX6218E (xx)
MY (1) MY8400200A (xx)
NL (1) NL184833C (xx)
NO (1) NO154054C (xx)
NZ (1) NZ192927A (xx)
OA (1) OA06484A (xx)
PT (1) PT70882A (xx)
SE (1) SE435180B (xx)
SG (1) SG22683G (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
NZ192927A (en) 1981-07-13
FR2451370B1 (xx) 1983-05-13
NL8001289A (nl) 1980-09-12
FI66357C (fi) 1984-10-10
AU533547B2 (en) 1983-12-01
MX6218E (es) 1984-12-21
NO800664L (no) 1980-09-11
DE3016752C2 (xx) 1987-06-25
EG14282A (en) 1983-09-30
NO154054B (no) 1986-04-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
DE3009071C2 (de) 1985-11-14
NL184833B (nl) 1989-06-16
CA1132561A (en) 1982-09-28
GB2045756A (en) 1980-11-05
NL184468B (nl) 1989-03-01
NL184833C (nl) 1989-11-16
HK55383A (en) 1983-11-25
NO154054C (no) 1986-07-09
LU82185A1 (fr) 1980-06-06
AR222691A1 (es) 1981-06-15
OA06484A (fr) 1981-07-31
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
DE3016752A1 (de) 1980-12-04
IN153791B (xx) 1984-08-18
FR2451191A1 (fr) 1980-10-10
FI66357B (fi) 1984-06-29
DE3050999A1 (xx) 1985-08-14
SE8001812L (sv) 1980-09-11
MY8400200A (en) 1984-12-31
FR2451191B1 (xx) 1983-04-29
BE881752A (fr) 1980-05-30
IE800477L (en) 1980-09-10
FR2451370A1 (fr) 1980-10-10
JPS6126996B2 (xx) 1986-06-23
FI800566A (fi) 1980-09-11
SG22683G (en) 1983-12-16
PT70882A (en) 1980-03-01
DE3050999C2 (de) 1986-08-14
DE3009071A1 (de) 1980-09-11

Similar Documents

Publication Publication Date Title
SE435180B (sv) Hydroxiderivat av 2-isopropylamino-pyrimidin och sett for framstellning derav
DE2607592A1 (de) Acetylenderivate von aminosaeuren sowie verfahren zu deren herstellung
DE2924681A1 (de) Phenylpiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
WO1997037988A1 (de) Acylierte n-hydroxymethyl thalidomid-prodrugs mit immunomodulatorischer wirkung
SE450251B (sv) Xantatforeningar for terapeutisk anvendning, nya xantatforeningar samt terapeutiska kompositioner innehallande dessa foreningar
US4324787A (en) 2-Oxo-1-pyrrolidineacetic acid compounds and their medicinal use
EP0688771A1 (de) Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE2720545B2 (de) Derivate des 2,4-Diamino-6,7-dimethoxychinazolins, ihre Herstellung und pharmazeutische Mittel
DE1949813B2 (de) 3-(4-PyrWyl)-4-(2-hydroxyphenyl)-5-alkyl-pyrazole
FI66359B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma hydroxiderivat av 2-isopropylamino-pyrimidin
DE2238280A1 (de) Furanderivate enthaltende arzneimittel und neue n-furoylmorpholinverbindungen
SE435177B (sv) Nya halogenderivat av 2-isopropylamino-pyrimidin och forfarande for framstellning derav
NO742091L (xx)
DE1643197A1 (de) Diarylcyclopropanderivate und Verfahren zu ihrer Herstellung
DE2618936C3 (de) N-Acyl-glutamine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
SE446530B (sv) Nya derivat av 6-metoxi-2-acetylnaftalenoxim, vilka derivat har analgetiska, antipyretiska och anti-inflammatoriska egenskaper
EP0388739A1 (de) Tetrahydronaphtalinderivate
DE3239719C2 (de) Uracil-Derivate, Verfahren zu ihrer Herstellung und dieselben enthaltende pharmazeutische Zusammensetzungen
EP3604291A1 (en) Compound or salt thereof, antiviral agent, and pharmaceutical composition
DE68927967T2 (de) 9-R-azazyklische Erythromycin-Antibiotika
KR840001708B1 (ko) 하이드록시 피리미딘 유도체의 제조방법
EP0001062B1 (de) Ergolin-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und ihre Anwendung bei therapeutischen Behandlungen
RU2702751C1 (ru) Производные пиримидина, обладающие модуляторной активностью по отношению к рецепторам амра-типа
SE446865B (sv) Nya derivat av 1,3-bensoxazin-2,4-dion, forfarande for framstellning derav samt farmaceutiska kompositioner
DE1620200C3 (de) 7-Oxo-desacetamido-colchicinderivate, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel. Ausscheidung aus: 1235322

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8001812-0

Effective date: 19910117

Format of ref document f/p: F